ArcherDX to Go Above and Beyond in Advanced Cancer Detection

Molecular diagnostics company, ArcherDX, has its technology platform for genetic mutation detection in cancer patients laid out. Now, the company is positioned to take its research and systems even further, after receiving $55 million in financing from several investors...